A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys XEN45 Glaucoma Implant in Subjects with Refractory Glaucoma

This study is currently recruiting participants.

Purpose: This is a prospective, Multicenter Clinical Trial Designed to evaluate the safety and IOP lowering performance of the AqueSys XEN45 Glaucoma Implant in refractory glaucoma patients where previous filtering or cilioablative procedures have failed, or byexperience is known to not provide satisfactory results, or IOP has been unresponsive to maximally tolerated medication.

Eligibility:

Contact Information

Dr. Joseph Panarelli, Glaucoma Specialist

Priya Mehta, Clinical Research Coordinator at 212-979-4672 or pmehta@nyee.edu

 

Home > Current Research > Clinical Trials in Ophthalmology > A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys XEN45 Glaucoma Implant in Subjects with Refractory Glaucoma